The ovine plasminogen activator inhibitors type 1 and type 2 cDNAs: Molecular cloning, characterization and expression in various tissues

Gene

Volumn 454, Issue 1-2, 2010, Pages 20-30

  Theodorou, Giorgos ^a   Bizelis, Iosif ^a   Rogdakis, Emmanuel ^a   Politis, Ioannis ^a  

^a AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

Adipose; CDNA; Homologue model; Mammary gland; Ovine; PAI 1; PAI 2

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADIPOSE TISSUE; AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BREAST; CONTROLLED STUDY; DNA ISOLATION; DNA STRUCTURE; EWE; FEMALE; GENETIC CODE; LACTATION; MAMMARY GLAND; MOLECULAR CLONING; NONHUMAN; PLASMINOGEN ACTIVATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; ENDOCRINE GLAND; ENERGY METABOLISM; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SEQUENCE HOMOLOGY; SHEEP; UDDER;

OVIS;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; ADIPOSE TISSUE; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ENDOCRINE GLANDS; ENERGY METABOLISM; FEMALE; HUMANS; LACTATION; MAMMARY GLANDS, ANIMAL; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; SEQUENCE HOMOLOGY, AMINO ACID; SHEEP;

EID: 77952471827     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2010.01.004     Document Type: Article

References (39)

1. Alessi M.C., Juhan-Vague I. PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler. Thromb. Vasc. Biol. 2006, 10:2200-2207.
2. Alessi M.C., Peiretti F., Morange P., Henry M., Nalbone G., Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997, 46:860-867.
3. Belin D. Biology and facultative secretion of plasminogen activator inhibitor-2. Thromb. Haemost. 1993, 70:144-147.
4. Bloor C.M., Nimmo L., McKirnan M.D., Zhang Y., White F.C. Increased gene expression of plasminogen activators and inhibitors in left ventricular hypertrophy. Mol. Cell. Biochem. 1997, 176:265-271.
5. Bruch M., Weiss V., Engel J. Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sites. J. Biol. Chem. 1988, 263:16630.
6. Bulcao C., Ferreira S.R., Giuffrida F.M., Ribeiro-Filho F.F. The new adipose tissue and adipocytokines. Curr. Diabetes Rev. 2006, 2:19-28.
7. Busso N., Huarte J., Vassalli J.D., Sappino A.P., Belin D. Plasminogen activators in the mouse mammary gland. Decreased expression during lactation. J. Biol. Chem. 1989, 264:7455-7457.
8. Cao M., Buratini J., Lussier J.G., Carriere P.D., Price C.A. Expression of protease nexin-1 and plasminogen activators during follicular growth and the periovulatory period in cattle. Reproduction 2006, 131:125-137.
9. Charismiadou M.A., Bizelis J.A., Rogdakis E. Metabolic changes during the perinatal period in dairy sheep in relation to level of nutrition and breed. I. Late pregnancy. J. Anim. Physiol. Anim. Nutr. 2000, 84:61-72.
10. Correia M.L.G., Haynes W.G. A role for plasminogen activator inhibitor-1 in obesity: from pie to PAI?. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2183-2185.
11. Crandall D.L., Groeling T.M., Busler D.E., Antrilli T.M. Release of PAI-1 by human preadipocytes and adipocytes independent of insulin and IGF-1. Biochem. Biophys. Res. Commun. 2000, 279:984-988.
12. Di Giusto D.A., Sutherland A.P., Jankova L., Harrop S.J., Curmi P.M., King G.C. Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution-implications for serpin mechanistic model and prediction of nsSNP activities. J. Mol. Biol. 2005, 353:1069-1080.
13. Fay W.P., Garg N., Sunkar M. Vascular functions of the plasminogen activation system. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1231-1237.
14. Felsenstein J. PHYLIP - Phylogeny Inference Package. Cladistics 1989, 5:164-166.
15. Ginsburg D., Zeheb R., Yang A.Y., Rafferty U.M., Andreasen P.A., Nielsen L., Dano K., Lebo R.V., Gelehrter T.D. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J. Clin. Invest. 1986, 78:1673-1680.
16. Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997, 18:2714-2723.
17. Hauner H. Secretory factors from human adipose tissue and their functional role. Proc. Nutr. Soc. 2005, 64:163-169.
18. He G., Bruun J.M., Lihn A.S., Pedersen S.B., Richelsen B. Stimulation of PAI-1 and adipokines by glucose in human adipose tissue in vitro. Biochem. Biophys. Res. Commun. 2003, 310:878-883.
19. Jones D.T. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol. 1999, 292:195-202.
20. Knight C.H., Wilde C.J. Mammary cell changes during pregnancy and lactation. Livest. Prod. Sci. 1993, 35:3-19.
21. Kozak M. Mechanism of mRNA recognition by eukaryotic ribosomes during initiation of protein synthesis. Curr. Top. Microbiol. Immunol. 1981, 93:81-123.
22. Lawrence D.A. The serpin-proteinase complex revealed. Nat. Struct. Biol. 1997, 4:341.
23. Liang X., Kanjanabuch T., Mao S.L., Hao C.M., Tang Y.W., Declerck P.J., Hasty A.H., Wasserman D.H., Fogo A.B., Ma L.J. Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am. J. Physiol. Endocrinol. Metabol. 2006, 290:103-113.
24. Lijnen H.R., Frederix L., Scroyen I. Deficiency of plasminogen activator inhibitor-2 impairs nutritionally induced murine adipose tissue development. J. Thromb. Haemost. 2007, 5:2259-2265.
25. Lund L.R., Romer J., Thomasset N., Solberg H., Pyke C., Bissell M.J., Dano K., Werb Z. Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 1996, 122:181-193.
26. Masuda Y., Emoto N., Nonaka H., Yagita K., Todo T., Okamura H., Yokoyama M., Hirata K. Role of angiotensin and the clock system in the circadian regulation of plasminogen activator inhibitor-1. Kobe J. Med. Sci. 2009, 54:264-271.
27. Medcalf R.L., Stasinopoulos S.J. The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2. FEBS J. 2005, 272:4858-4867.
28. Mikus P., Ny T. Intracellular polymerization of the serpin plasminogen activator inhibitor type 2. J. Biol. Chem. 1996, 271:10048-10053.
29. Mondino A., Blasi F. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol. 2004, 25:450-455.
30. Morange P.E., Alessi M.C., Verdier M., Casanova D., Magalon G., Juhan-Vague I. PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1361-1365.
31. Politis I. Plasminogen activator system: implications for mammary cell growth and involution. J. Dairy Sci. 1996, 79:1097-1107.
32. Politis I., Zavizjon B., Cheli F., Baldi A. Expression of urokinase plasminogen activator receptor in resting and activated bovine neutrophils. J. Dairy Res. 2002, 69:195-204.
33. Rabot A., Sinowatz F., Berisha B., Meyer H.H., Schams D. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution. J. Dairy Sci. 2007, 90:740-748.
34. Salonen E.M., Vaheri A., Pollanen J., Stephens R., Andreasen P., Mayer M., Dano K., Gailit J., Ruoslahti E. Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. J. Biol. Chem. 1989, 263:15454-15461.
35. Sharp A.M., Stein P.E., Pannu N.S., Carrell R.W., Berkenpas M.B., Ginsburg D., Lawrence D.A., Read R.J. The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion. Structure 1999, 7:111-118.
36. Silverman G.A., Bird P.I., Carrell R.W., Church F.C., Coughlin P.B., Gettins P.G., Irving J.A., Lomas D.A., Luke C.J., Moyer R.W., Pemberton P.A., Remold-O'Donnell E., Salvesen G.S., Travis J., Whisstock J.C. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 2001, 276:33293-33296.
37. Theodorou G., Bizelis I., Rogdakis E., Politis I. The ovine urokinase plasminogen activator and its receptor cDNAs: molecular cloning, characterization and expression in various tissues. Gene 2009, 443:158-169.
38. Wozniak S.E., Gee L.L., Wachtel M.S., Frezza E.E. Adipose tissue: the new endocrine organ? A review article. Dig. Dis. Sci. 2009, 54:1847-1856.
39. Ye R.D., Wun T.C., Sadler J.E. cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta. J. Biol. Chem. 1987, 262:3718-3725.